Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host diseaseAnita G. Koshy, Jacalyn Rosenblatt, Michele Narcis et al.|Blood|2023Cited by 16
Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapyMatt Weinstock, Jon Arnason, Pavania Elavalakanar et al.|British Journal of Haematology|2022Cited by 7
G-CSF Administration Is Associated with Worse Treatment Response and Survival after CAR T-Cell TherapyPoorva Bindal, Jon Arnason, Pavania Elavalakanar et al.|Blood|2022Cited by 4
Phase II Clinical Trial of Abatacept for Steroid-Refractory Chronic Graft Versus Host DiseaseAnita G. Koshy, Jacalyn Rosenblatt, Haesook T. Kim et al.|Blood|2021Cited by 3
Corticosteroids, Tocilizumab or Filgrastim Do Not Impact the Efficacy of CAR T-Cell Therapy with 4- 1BB Costimulatory DomainPoorva Bindal, Jon Arnason, Laura E. Dodge et al.|Transplantation and Cellular Therapy|2022Cited by 0